145
Participants
Start Date
March 26, 2015
Primary Completion Date
June 5, 2019
Study Completion Date
May 20, 2022
low dosage HPV Vaccine
Participants would intramuscularly receive low dosage of HPV 6/11 bivalent vaccine at 0, 1, 6 month for 3 doses.
medium dosage HPV Vaccine
Participants would intramuscularly receive medium dosage of HPV 6/11 bivalent vaccine at 0, 1, 6 month for 3 doses.
high dosage HPV Vaccine
Participants would intramuscularly receive high dosage of HPV 6/11 bivalent vaccine at 0, 1, 6 month for 3 doses.
Aluminium Adjuvant
Participants would intramuscularly receive aluminium adjuvant at 0, 1, 6 month for 3 doses.
Xiamen Innovax Biotech Co., Ltd
INDUSTRY
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
INDUSTRY
Jun Zhang
OTHER